Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm

Abstract

Background

The safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysms remains unclear.

Aims

This study was performed to determine whether treatment with antiplatelets, anticoagulants, or intravenous thrombolytic agents is safe for patients with acute ischemic stroke and unruptured intracranial aneurysms.

Methods

Among 9149 patients with acute ischemic stroke enrolled in the Fukuoka Stroke Registry from June 2007 to December 2014, 8857 patients with data on cerebrovascular imaging and three-month outcomes were included in this study. The frequency of adverse events, including intracranial hemorrhage, symptomatic intracranial hemorrhage, and in-hospital mortality, was compared between patients with and without unruptured intracranial aneurysms. The risk of a poor functional outcome (modified Rankin scale score of ≥3) at three months after stroke onset was estimated after adjusting for confounding factors by logistic regression analysis.

Results

Unruptured intracranial aneurysms were identified in 412 (4.7%) patients, and the mean diameter was 4.1 ± 3.2 mm. There was no significant difference in the frequency of any adverse events between patients with and without unruptured intracranial aneurysms among the overall patients or patients receiving antiplatelets, anticoagulants, or intravenous thrombolytic agents. The odds ratios of a poor functional outcome were not significantly higher in the presence of unruptured intracranial aneurysms, even in patients undergoing antiplatelet therapy, anticoagulation therapy, or intravenous thrombolysis.

Conclusions

These findings suggest that unruptured intracranial aneurysms are not associated with increased risks of adverse events or poor functional outcomes even after antithrombotic therapy for acute ischemic stroke. However, accumulation of cases is required to verify these findings.

Keywords

Anticoagulation antiplatelet therapy ischemic stroke safety thrombolysis unruptured intracranial aneurysm

Get full access to this article

View all access options for this article.

References

Vlak

Algra

Brandenburg

Rinkel

. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011; 10: 626–636.

Vernooij

Ikram

Tanghe

et al.

Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357: 1821–1828.

Kang

Kim

Lee

et al.

Risk factors associated with the presence of unruptured intracranial aneurysms. Stroke 2015; 46: 3093–3098.

Ishikawa

Hirayama

Nakamura

Ikeda

. Incidental cerebral aneurysms in acute stroke patients: comparison of asymptomatic healthy controls. J Neurol Sci 2010; 298: 42–45.

Lee

Shon

Yang

Kim

Cho

. Incidental unruptured intracranial aneurysms in patients with acute ischemic stroke. Cerebrovasc Dis 2008; 26: 650–653.

International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms – risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339: 1725–1733.

Wiebers

Whisnant

Huston

J 3rd

et al.

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362: 103–110.

Morita

Kirino

Hashi

et al. UCAS Japan Investigators . The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012; 366: 2474–2482.

Kamouchi

Matsuki

Hata

et al.

Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke 2011; 42: 2788–2794.

10.

Adams

Jr Bendixen

Kappelle

et al.

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.

11.

Iwamoto

Kiyohara

Fujishima

et al.

Prevalence of intracranial saccular aneurysms in a Japanese community based on a consecutive autopsy series during a 30-year observation period. The Hisayama study. Stroke 1999; 30: 1390–1395.

12.

Thien

See

Ang

et al.

Prevalence of asymptomatic unruptured intracranial aneurysms in a southeast asian population. World Neurosurg 2017; 97: 326–332.

13.

Schievink

. Intracranial aneurysms. N Engl J Med 1997; 336: 28–40.

14.

Schmidt

Johansen

Lash

Christiansen

Christensen

Sorensen

. Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study. J Thromb Haemost 2010; 8: 1468–1474.

15.

Garcia-Rodriguez

Gaist

Morton

Cookson

Gonzalez-Perez

. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology 2013; 81: 566–574.

16.

Edwards

Kamel

Josephson

. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Stroke 2012; 43: 412–416.

17.

Kim

Park

Yoon

Cho

. Detection and significance of incidental unruptured cerebral aneurysms in patients undergoing intravenous thrombolysis for acute ischemic stroke. J Neuroimaging 2012; 22: 197–200.

18.

Sheth

Shah

Morovati

Hermann

Cronin

. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms. Neurocrit Care 2012; 17: 199–203.

19.

Mittal

Seet

Zhang

Brown

Jr Rabinstein

. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. J Stroke Cerebrovasc Dis 2013; 22: 639–643.

20.

Zhang

Wang

et al.

Efficacy and safety of intravenous thrombolysis for the treatment of acute ischemic stroke patients with saccular intracranial aneurysms of ≤ 3 mm. Cell Biochem Biophys 2015; 72: 889–893.

21.

Ding

Han

Jing

Jiang

. Is it dangerous to treat acute ischemic stroke by thrombolytic therapy in patients with comorbid intracranial aneurysms? Am J Emerg Med 2016; 34: 636–642.

22.

Matsumaru

Hyodo

Okazaki

Nose

. A pitfall of fibrinolysis. Aneurysms found after attempted fibrinolytic therapy of occluded arteries. Interv Neuroradiol 1998; 4: 165–169.

23.

Haji

van Adel

Avery

Megyesi

Young

. Intracranial aneurysm rupture following intravenous thrombolysis for stroke. Can J Neurol Sci 2014; 41: 95–98.

24.

Rammos

Neils

Fraser

Klopfenstein

. Anterior communicating artery aneurysm rupture after intravenous thrombolysis for acute middle cerebral artery thromboembolism: case report. Neurosurgery 2012; 70: E1603–E1607.

25.

Zaldivar-Jolissaint

Messerer

Bervini

Mosimann

Levivier

Daniel

. Rupture of a concealed aneurysm after intravenous thrombolysis of a thrombus in the parent middle cerebral artery. J Stroke Cerebrovasc Dis 2015; 24: e63–e65.

26.

Torikoshi

Akiyama

. A concealed intracranial aneurysm detected after recanalization of an occluded vessel: a case report and literature review. Intervent Neurol 2015; 4: 90–95.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.47 MB